Analyst says he’s thrown in the towel on Novo Nordisk after latest setback
Up next
Author


Novo Nordisk’s study showing a new drug wasn’t as good as a rival’s led one sell-side analyst to downgrade the stock for the first time in five years.

You May Also Like
ECB decision: Rates expected to come down to nearly two-year low

ECB decision: Rates expected to come down to nearly two-year low

The European Central Bank is expected to cut interest rates as the…
Goldman Sachs managing director makes the case for a modified low-volatility ETF

Goldman Sachs managing director makes the case for a modified low-volatility ETF

Laurene Azoulay describes an indexing approach that enables U.S. investors to broaden…
Trump wants to let you take money from your 401(k) to buy a house. Putting it back is complicated.

Trump wants to let you take money from your 401(k) to buy a house. Putting it back is complicated.

If you can avoid the 10% penalty, does that make it a…

Live news: Investors pull $7.7bn from Franklin Templeton unit amid co-CIO probe

The Nasdaq Composite notched its best one-day rise in a month after…